Bullfrog AI Holdings, Inc. (NASDAQ:BFRG – Get Free Report) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 339,500 shares, an increase of 18.7% from the March 15th total of 286,000 shares. Based on an average daily volume of 820,100 shares, the short-interest ratio is currently 0.4 days. Approximately 5.0% of the shares of the company are short sold.
Insider Activity at Bullfrog AI
In other Bullfrog AI news, CEO Vininder Singh sold 27,958 shares of the firm’s stock in a transaction on Thursday, April 3rd. The stock was sold at an average price of $1.44, for a total value of $40,259.52. Following the sale, the chief executive officer now directly owns 2,348,341 shares in the company, valued at approximately $3,381,611.04. This trade represents a 1.18 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 33.90% of the company’s stock.
Institutional Trading of Bullfrog AI
Large investors have recently added to or reduced their stakes in the business. Raymond James Financial Inc. acquired a new position in Bullfrog AI during the 4th quarter worth $30,000. Two Sigma Securities LLC bought a new position in Bullfrog AI in the 4th quarter valued at about $41,000. Finally, Geode Capital Management LLC increased its stake in Bullfrog AI by 31.0% during the 4th quarter. Geode Capital Management LLC now owns 47,093 shares of the company’s stock valued at $94,000 after buying an additional 11,140 shares during the period. 0.96% of the stock is currently owned by institutional investors and hedge funds.
Bullfrog AI Stock Performance
Bullfrog AI (NASDAQ:BFRG – Get Free Report) last posted its earnings results on Friday, March 14th. The company reported ($0.18) EPS for the quarter.
About Bullfrog AI
Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.
See Also
- Five stocks we like better than Bullfrog AI
- The Role Economic Reports Play in a Successful Investment Strategy
- How to Invest in Micro-Cap Stocks Like a Pro
- Consumer Discretionary Stocks Explained
- Investors Sell Microsoft Stock on OpenAI News—Time to Buy?
- How to Invest in Blue Chip Stocks
- Take-Two Interactive: A Defensive Play Set to Explode
Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.